» Articles » PMID: 27186885

Cholera Incidence and Mortality in Sub-Saharan African Sites During Multi-country Surveillance

Abstract

Background: Cholera burden in Africa remains unknown, often because of weak national surveillance systems. We analyzed data from the African Cholera Surveillance Network (www.africhol.org).

Methods/ Principal Findings: During June 2011-December 2013, we conducted enhanced surveillance in seven zones and four outbreak sites in Togo, the Democratic Republic of Congo (DRC), Guinea, Uganda, Mozambique and Cote d'Ivoire. All health facilities treating cholera cases were included. Cholera incidences were calculated using culture-confirmed cholera cases and culture-confirmed cholera cases corrected for lack of culture testing usually due to overwhelmed health systems and imperfect test sensitivity. Of 13,377 reported suspected cases, 34% occurred in Conakry, Guinea, 47% in Goma, DRC, and 19% in the remaining sites. From 0-40% of suspected cases were aged under five years and from 0.3-86% had rice water stools. Within surveillance zones, 0-37% of suspected cases had confirmed cholera compared to 27-38% during outbreaks. Annual confirmed incidence per 10,000 population was <0.5 in surveillance zones, except Goma where it was 4.6. Goma and Conakry had corrected incidences of 20.2 and 5.8 respectively, while the other zones a median of 0.3. During outbreaks, corrected incidence varied from 2.6 to 13.0. Case fatality ratios ranged from 0-10% (median, 1%) by country.

Conclusions/significance: Across different African epidemiological contexts, substantial variation occurred in cholera incidence, age distribution, clinical presentation, culture confirmation, and testing frequency. These results can help guide preventive activities, including vaccine use.

Citing Articles

Navigating water crisis, cholera, and refugee context: Lessons from Nakivale refugee settlement, Isingiro District, Uganda.

Aceng F, Kintu B, Habumugisha J, Kayanja S, Wanyoto F, Asiimire M PLOS Glob Public Health. 2025; 5(2):e0004201.

PMID: 39903796 PMC: 11793826. DOI: 10.1371/journal.pgph.0004201.


Rapid cholera outbreak control following catastrophic landslides and floods: A case study of Bududa district, Uganda.

Bwire G, Tumuhairwe I, Kwagonza L, Wetaka M, Nakinsige A, Arinitwe E Afr Health Sci. 2024; 23(4):203-215.

PMID: 38974278 PMC: 11225440. DOI: 10.4314/ahs.v23i4.23.


Enhanced cholera surveillance to improve vaccination campaign efficiency.

Xu H, Zou K, Dent J, Wiens K, Malembaka E, Bwire G Nat Med. 2024; 30(4):1104-1110.

PMID: 38443690 PMC: 11031394. DOI: 10.1038/s41591-024-02852-8.


Estimating the proportion of clinically suspected cholera cases that are true Vibrio cholerae infections: A systematic review and meta-analysis.

Wiens K, Xu H, Zou K, Mwaba J, Lessler J, Malembaka E PLoS Med. 2023; 20(9):e1004286.

PMID: 37708235 PMC: 10538743. DOI: 10.1371/journal.pmed.1004286.


Inadequate Hand Washing, Lack of Clean Drinking Water and Latrines as Major Determinants of Cholera Outbreak in Somali Region, Ethiopia in 2019.

Challa J, Getachew T, Debella A, Merid M, Atnafe G, Eyeberu A Front Public Health. 2022; 10:845057.

PMID: 35602140 PMC: 9120658. DOI: 10.3389/fpubh.2022.845057.


References
1.
Alam M, Hasan N, Sultana M, Nair G, Sadique A, Faruque A . Diagnostic limitations to accurate diagnosis of cholera. J Clin Microbiol. 2010; 48(11):3918-22. PMC: 3020846. DOI: 10.1128/JCM.00616-10. View

2.
Sur D, Lopez A, Kanungo S, Paisley A, Manna B, Ali M . Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2009; 374(9702):1694-702. DOI: 10.1016/S0140-6736(09)61297-6. View

3.
Ali M, Lopez A, You Y, Kim Y, Sah B, Maskery B . The global burden of cholera. Bull World Health Organ. 2012; 90(3):209-218A. PMC: 3314202. DOI: 10.2471/BLT.11.093427. View

4.
Djingarey M, Barry R, Bonkoungou M, Tiendrebeogo S, Sebgo R, Kandolo D . Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Vaccine. 2012; 30 Suppl 2:B40-5. DOI: 10.1016/j.vaccine.2011.12.073. View

5.
Guerra J, Mayana B, Djibo A, Manzo M, Llosa A, Grais R . Evaluation and use of surveillance system data toward the identification of high-risk areas for potential cholera vaccination: a case study from Niger. BMC Res Notes. 2012; 5:231. PMC: 3413562. DOI: 10.1186/1756-0500-5-231. View